BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+18.18%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$478M
AUM Growth
+$478M
(-7%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-21.87%
Top 10 Holdings %
Top 10 Hldgs %
71.33%
Holding
32
New
1
Increased
7
Reduced
12
Closed
1
Top Buys
| 1 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
$9.64M |
| 2 |
QLTI
QLT Inc
QLTI
|
$5.86M |
| 3 |
FWP
Forward Pharma A/S American Depositary Shares
FWP
|
$3.54M |
| 4 |
ARQL
Arqule Inc
ARQL
|
$3.25M |
| 5 |
Exelixis
EXEL
|
$2.04M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$46.8M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$45.7M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$17.4M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$7.39M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$3.82M |
Sector Composition
| 1 | Healthcare | 62.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $69.3M | 14.5% | 9,405,817 -2,366,518 | -20% | -$17.4M |
|
|
CCXI
2
DELISTED
ChemoCentryx, Inc.
CCXI
| $62.7M | 13.11% | 8,303,084 -293,688 | -3% | -$2.22M |
|
|
3
Ironwood Pharmaceuticals
IRWD
$214M
| $34.7M | 7.26% | 2,171,108 -2,922,702 | -57% | -$46.8M |
|
|
FWP
4
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $33.3M | 6.97% | 1,177,481 +125,100 | +12% | +$3.54M |
|
|
OMED
5
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $33.1M | 6.92% | 1,284,115 -90,700 | -7% | -$2.34M |
|
|
CASC
6
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $23.3M | 4.88% | 14,314,178 +551,918 | +4% | +$900K |
|
|
7
Ligand Pharmaceuticals
LGND
$3.15B
| $20.6M | 4.31% | 267,090 -592,973 | -69% | -$45.7M |
|
|
CNCE
8
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $20.3M | 4.25% | 1,340,659 +134,200 | +11% | +$2.03M |
|
9
Gyre Therapeutics
GYRE
$703M
| $19.8M | 4.13% | 6,655,128 | – | – |
|
|
VTAE
10
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $18.5M | 3.86% | 1,577,435 +823,500 | +109% | +$9.64M |
|
|
QLTI
11
DELISTED
QLT Inc
QLTI
| $16.2M | 3.39% | 4,149,862 +1,499,299 | +57% | +$5.86M |
|
12
Cytokinetics
CYTK
$4.23B
| $14.3M | 2.99% | 2,106,989 -336,111 | -14% | -$2.28M |
|
|
LOXO
13
DELISTED
Loxo Oncology, Inc
LOXO
| $14M | 2.93% | 1,125,665 -65,037 | -5% | -$810K |
|
|
ARQL
14
DELISTED
Arqule Inc
ARQL
| $13.8M | 2.89% | 6,174,561 +1,450,750 | +31% | +$3.25M |
|
|
15
Exelixis
EXEL
$10.1B
| $12.8M | 2.68% | 4,988,357 +793,005 | +19% | +$2.04M |
|
|
FPRX
16
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $11.5M | 2.4% | 502,832 -323,500 | -39% | -$7.39M |
|
|
ONCT
17
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $7.51M | 1.57% | 11,111,111 | – | – |
|
|
18
Xenon Pharmaceuticals
XENE
$2.98B
| $6.6M | 1.38% | 391,424 -226,800 | -37% | -$3.82M |
|
|
VIRX
19
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.64M | 0.97% | 1,893,030 -1,242,970 | -40% | -$3.05M |
|
20
Savara
SVRA
$567M
| $3.51M | 0.73% | 7,241,600 -50,000 | -0.7% | -$24.2K |
|
|
BLRX
21
BioLineRX
BLRX
$16.2M
| $3.17M | 0.66% | 1,501,000 | – | – |
|
22
Achieve Life Sciences
ACHV
$152M
| $2.94M | 0.62% | 1,368,500 | – | – |
|
|
TBRA
23
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $2.3M | 0.48% | 1,882,521 | – | – |
|
|
AKAO
24
DELISTED
Achaogen, Inc.
AKAO
| $1.33M | 0.28% | 136,600 | – | – |
|
25
MEI Pharma
MEIP
$160M
| $1.07M | 0.22% | +600,000 | New | +$1.07M |
|